Meritage Portfolio Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$5.07M Sell
15,490
-483
-3% -$153K 0.34% 85
2025
Q3
$4.51M Sell
15,973
-1,504
-9% -$436K 0.3% 99
2025
Q2
$4.88M Sell
17,477
-213
-1% -$60.3K 0.31% 92
2025
Q1
$5.51M Sell
17,690
-280
-2% -$82.7K 0.37% 74
2024
Q4
$4.68M Sell
17,970
-6,639
-27% -$1.97M 0.29% 93
2024
Q3
$7.93M Sell
24,609
-571
-2% -$187K 0.49% 53
2024
Q2
$7.87M Sell
25,180
-310
-1% -$91.1K 0.5% 54
2024
Q1
$7.25M Sell
25,490
-1,652
-6% -$483K 0.46% 59
2023
Q4
$7.82M Buy
27,142
+1,484
+6% +$404K 0.52% 46
2023
Q3
$6.9M Sell
25,658
-733
-3% -$183K 0.51% 55
2023
Q2
$5.86M Sell
26,391
-1,671
-6% -$388K 0.41% 76
2023
Q1
$6.78M Buy
28,062
+35
+0.1% +$8.59K 0.51% 63
2022
Q4
$7.36M Sell
28,027
-308
-1% -$82.6K 0.58% 48
2022
Q3
$6.39M Sell
28,335
-975
-3% -$236K 0.53% 50
2022
Q2
$7.13M Buy
+29,310
New +$7.18M 0.55% 47
2021
Q3
Sell
-10,955
Closed -$2.67M 316
2021
Q2
$2.67M Buy
10,955
+69
+0.6% +$17K 0.16% 157
2021
Q1
$2.71M Buy
+10,886
New +$2.6M 0.18% 147
2020
Q4
Sell
-8,961
Closed -$2.28M 256
2020
Q3
$2.28M Sell
8,961
-825
-8% -$204K 0.2% 133
2020
Q2
$2.31M Sell
9,786
-1,010
-9% -$230K 0.22% 133
2020
Q1
$2.19M Sell
10,796
-33,096
-75% -$7.23M 0.3% 102
2019
Q4
$10.6M Sell
43,892
-147
-0.3% -$32.4K 0.93% 22
2019
Q3
$8.52M Buy
44,039
+25,561
+138% +$4.91M 0.81% 28
2019
Q2
$3.4M Buy
+18,478
New +$3.31M 0.35% 111
2019
Q1
Sell
-42,995
Closed -$8.37M 183
2018
Q4
$8.37M Sell
42,995
-1,147
-3% -$224K 0.96% 21
2018
Q3
$9.15M Sell
44,142
-352
-0.8% -$69.4K 0.84% 20
2018
Q2
$8.21M Sell
44,494
-378
-0.8% -$66.9K 0.8% 21
2018
Q1
$7.65M Buy
44,872
+897
+2% +$165K 0.74% 28
2017
Q4
$7.65M Sell
43,975
-696
-2% -$123K 0.73% 29
2017
Q3
$8.33M Buy
44,671
+86
+0.2% +$15.2K 0.82% 25
2017
Q2
$7.68M Sell
44,585
-1,145
-3% -$186K 0.79% 26
2017
Q1
$7.5M Buy
45,730
+230
+0.5% +$38.2K 0.79% 28
2016
Q4
$6.65M Sell
45,500
-362
-0.8% -$54.5K 0.73% 44
2016
Q3
$7.65M Sell
45,862
-204
-0.4% -$34.5K 0.84% 26
2016
Q2
$7.01M Sell
46,066
-577
-1% -$89.7K 0.79% 31
2016
Q1
$6.99M Sell
46,643
-502
-1% -$74.6K 0.79% 32
2015
Q4
$7.65M Buy
47,145
+21,328
+83% +$3.35M 0.86% 21
2015
Q3
$3.57M Buy
25,817
+892
+4% +$141K 0.41% 129
2015
Q2
$3.83M Sell
24,925
-6,414
-20% -$1.03M 0.4% 148
2015
Q1
$5.01M Buy
31,339
+487
+2% +$76.7K 0.5% 100
2014
Q4
$4.92M Sell
30,852
-148
-0.5% -$23.1K 0.52% 86
2014
Q3
$4.35M Sell
31,000
-660
-2% -$86.2K 0.5% 108
2014
Q2
$3.75M Buy
31,660
+420
+1% +$48.6K 0.41% 150
2014
Q1
$3.85M Buy
31,240
+24,602
+371% +$2.98M 0.46% 124
2013
Q4
$757K Buy
6,638
+38
+0.6% +$4.32K 0.09% 169
2013
Q3
$739K Hold
6,600
0.1% 172
2013
Q2
$651K Buy
+6,600
New +$685K 0.09% 168

Other funds holding AMGN

Meritage Portfolio Management's AMGN Position: Q4 2025 in Review

Meritage Portfolio Management reduced its Amgen (AMGN) stake by 3% in Q4 2025, selling an estimated $153K and leaving 15,490 shares worth $5.07M. The position accounts for 0.34% of the portfolio, ranked #85.

Meritage Portfolio Management first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.6M in Q4 2019. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Meritage Portfolio Management held 15,490 shares of Amgen worth $5.07M as of Q4 2025.
  • Meritage Portfolio Management sold 483 Amgen shares in Q4 2025, an estimated $153K.
  • Amgen made up 0.34% of Meritage Portfolio Management's portfolio in Q4 2025, its #85 holding.
  • Meritage Portfolio Management first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
  • Meritage Portfolio Management's Amgen position peaked at $10.6M in Q4 2019.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.